Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cambrex Corp (NYSE:CBM)

58.60
Delayed Data
As of 4:02pm ET
 -0.20 / -0.34%
Today’s Change
38.30
Today|||52-Week Range
62.50
+8.62%
Year-to-Date
No recent news for Cambrex Corp.

Today’s Trading

Previous close58.80
Today’s open58.75
Day’s range58.60 - 59.35
Volume326,394
Average volume (3 months)333,998
Market cap$2.0B
Dividend yield--
Data as of 4:02pm ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)+40.91%
Earnings growth (this year)+4.18%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+13.23%
P/E ratio22.1
Price/Sales3.63
Price/Book4.69

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...+0.06+0.11%
SRPTSarepta Therapeutics...-0.14-0.40%
PCRXPacira Pharmaceutica...+0.75+1.59%
TBPHTheravance Biopharma...-0.10-0.25%
Data as of 3:59pm ET, 04/27/2017

Financials

Next reporting dateMay 5, 2017
EPS forecast (this quarter)$0.48
Annual revenue (last year)$490.6M
Annual profit (last year)$81.7M
Net profit margin17.80%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
President, Chief Executive Officer &
Director
Steven M. Klosk
Chief Operating Officer &
Executive Vice President
Shawn P. Cavanagh
Corporate headquarters
East Rutherford, New Jersey

Forecasts